Covered recipient · General Payments record
DEBORAH A KEOHAN
Physician Assistants & Advanced Practice Nursing Providers Clinical Nurse Specialist
General Payments · PY2022–2023
$388.36
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $123.75 | 7 |
| Education | $37.98 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $67.78 | 4 |
| Teva Pharmaceuticals USA, Inc. | $40.08 | 2 |
| ITI, Inc. | $22.63 | 1 |
| Corium, Inc. | $17.46 | 1 |
| Neurocrine BioSciences, Inc. | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Corium, LLC | $17.46 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978213373 | CMS |
| ITI, Inc. | $22.63 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040978533 | CMS |
| Neurocrine Biosciences, Inc. | $13.78 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052236617 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.02 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055919777 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.59 | 01/24/2023 | Education | Undisputed | 01/23/2026 | 1055919783 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.39 | 01/24/2023 | Education | Undisputed | 01/23/2026 | 1055919787 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.78 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055919793 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.27 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056889129 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.81 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056889147 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.